We are live on ! Find out more
NARI

Inari Medical, Inc. Common Stock
NARI

Delisted

NARI was delisted on the 18th of February, 2025.

Back to rankings

252 hedge funds and large institutions have $3.24B invested in Inari Medical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 85 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 34

14% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 85

1% more funds holding

Funds holding: 250 → 252 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $3.3B → $3.24B (-$66.9M)

59% less call options, than puts

Call options by funds: $15.5M | Put options by funds: $38M

Holders
252
Holders Change
+2
Holders Change %
+0.8%
% of All Funds
3.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
97
Reduced
85
Closed
34
Calls
$15.5M
Puts
$38M
Net Calls
-$22.5M
Net Calls Change
+$1.2M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$40.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26M
3
SPC
Slate Path Capital
New York
+$25.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$19.6M
5
JP Morgan Chase
JP Morgan Chase
New York
+$17.5M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$52.9M
2
Norges Bank
Norges Bank
Norway
-$47.1M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$32.1M
4
Millennium Management
Millennium Management
New York
-$23.1M
5
IHAM
Integral Health Asset Management
New York
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
251
Principal Securities
Iowa
$649 +$602 +10 New
Toronto Dominion Bank
252
Toronto Dominion Bank
Ontario, Canada
$65 – – –
SAM
253
Sectoral Asset Management
Quebec, Canada
– -$9.03M -138,043 Closed
PM
254
Prosight Management
Texas
– -$8.5M -130,000 Closed
TD Asset Management
255
TD Asset Management
Ontario, Canada
– -$7.23M -110,520 Closed
Two Sigma Advisers
256
Two Sigma Advisers
New York
– -$4.7M -71,900 Closed
EW
257
Evoke Wealth
California
– -$4.1M -62,740 Closed
GGHC
258
Gilder Gagnon Howe & Co
New York
– -$3.4M -51,931 Closed
Los Angeles Capital Management
259
Los Angeles Capital Management
California
– -$2.66M -40,635 Closed
ACM
260
Aquatic Capital Management
Illinois
– -$2.37M -36,200 Closed
ECM
261
Element Capital Management
New York
– -$2.16M -33,056 Closed
DC
262
Diametric Capital
Massachusetts
– -$1.9M -29,045 Closed
HLA
263
Hamilton Lane Advisors
Pennsylvania
– -$1.63M -24,900 Closed
HF
264
HRT Financial
New York
– -$1.43M -21,902 Closed
MAG
265
Millrace Asset Group
Pennsylvania
– -$1.17M -17,825 Closed
N
266
Numerai
California
– -$1.02M -15,580 Closed
DFCM
267
Dark Forest Capital Management
Puerto Rico
– -$894K -13,668 Closed
PCH
268
Polar Capital Holdings
United Kingdom
– -$799K -12,224 Closed
BCM
269
Bayesian Capital Management
New York
– -$726K -11,100 Closed
GC
270
Guggenheim Capital
Illinois
– -$719K -11,001 Closed
JF
271
Jump Financial
Illinois
– -$687K -10,500 Closed
LP
272
LMR Partners
United Kingdom
– -$672K -10,280 Closed
SGI
273
Summit Global Investments
Utah
– -$520K -7,952 Closed
JFG
274
Jefferies Financial Group
New York
– -$500K -7,649 Closed
WG
275
Winton Group
United Kingdom
– -$448K -6,849 Closed
8 9 10
11
12

NARI Hedge Fund Activity: Q4 2023 in Review

252 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q4 2023, worth a combined $3.24B — down 2% from $3.3B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new NARI positions and 34 closed out — a net gain of 5 holders — while 97 added to existing stakes and 85 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $40.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $52.9M.

  • 252 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q4 2023, up from 250 in Q3 2023.
  • Funds reported $3.24B of Inari Medical, Inc. Common Stock stock for Q4 2023, down 2% quarter-over-quarter.
  • 39 funds opened new Inari Medical, Inc. Common Stock positions in Q4 2023 and 34 closed out, a net change of +5 holders.
  • The largest Inari Medical, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $40.3M added.
  • The largest Inari Medical, Inc. Common Stock seller in Q4 2023 was T. Rowe Price Associates, an estimated $52.9M sold.

Based on aggregated 13F filings for Q4 2023.